Loading organizations...
§ Private Profile · Cambridge, MA, USA
Medical device company developing data-driven hardware and software for diabetes care and injectable medicine management.
Cambridge, Massachusetts-based Common Sensing developed data-driven hardware and software medical devices designed to track and manage injectable medicines like insulin and fertility hormones. The company's primary product was the Gocap, a Bluetooth-connected smart cap for injector pens that logged dosage data to a mobile application and cloud platform for patient and clinician review. In 2016, the startup partnered with the Joslin Diabetes Center to conduct a clinical study involving 125 patients to evaluate the device's impact on insulin adherence and clinical outcomes. Common Sensing secured a $6.6 million Series A funding round in 2018 led by Waterline Ventures, with additional equity participation from minority investor Philips. The company's intellectual property assets and technology portfolio were subsequently acquired by Bigfoot Biomedical in June 2021. Common Sensing was founded in 2012 by James White and Richard Whalley.
Common Sensing has raised $6.6M across 1 funding round.
Common Sensing has raised $6.6M in total across 1 funding round.
Common Sensing has raised $6.6M in total across 1 funding round.
Common Sensing's investors include Waterline Ventures, Haselmeier, New World Health, Philips.
Common Sensing has raised $6.6M across 1 funding round. Most recently, it raised $6.6M Series A in April 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 11, 2018 | $6.6M Series A | Waterline Ventures | Haselmeier, NEW World Health, Philips | Announced |